IL-32: A newly-discovered proinflammatory cytokine

Journal of Biological Regulators and Homeostatic Agents

Volumn 23, Issue 3, 2009, Pages 141-147

  Felaco, P ^a   Castellani, Maria Luisa ^a   De Lutiis, M A ^a   Felaco, M ^a   Pandolfi, F ^b   Salini, V ^a   De Amicis, D ^a   Vecchiet, J ^a   Tete S ^a   Ciampoli, C ^a   Conti, F ^a   Cerulli, G ^c   Caraffa, A ^c   Antinolfi, P ^c   Cuccurullo, C ^a   Perrella, A ^d   Theoharides, T C ^e   Conti, P ^a   Toniato, E ^a   Kempuraj, D ^e   Shaik, Y B ^f   more..

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Cytokine; IL 32; Immunity; Inflammation; Interleukin

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 32; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADAPTIVE IMMUNITY; BONE MARROW CELL; BREAST CANCER; CELL DIFFERENTIATION; CELL MATURATION; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; EPITHELIUM CELL; HISTAMINE RELEASE; HUMAN; INFLAMMATORY DISEASE; INFLUENZA; INFLUENZA VIRUS A; INNATE IMMUNITY; LUNG CANCER; MAST CELL; MULTINUCLEAR CELL; NATURAL KILLER T CELL; NONHUMAN; OSTEOCLAST; PERITONEUM MAST CELL; REVIEW; RHEUMATOID ARTHRITIS; STOMACH CANCER; T LYMPHOCYTE; TUBERCULOSIS; ULCERATIVE COLITIS; UMBILICAL CORD BLOOD; ANIMAL; EDITORIAL; IMMUNITY; METABOLISM;

INFLUENZA A VIRUS; MYCOBACTERIUM TUBERCULOSIS; RATTUS;

ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNITY; INFLAMMATION MEDIATORS; INTERLEUKINS; NF-KAPPA B;

EID: 75349086443     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Wells AD. New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting. J Immunol 2009; 182:6088-6094
2. Ciardelli L, Garofoli F, Stronati M, et al. Human colostrum T lymphocytes and their effector cytokines actively aid the development of the newborn immune system. Int J Immunopathol Pharmacol. 2008; 21:781-786
3. Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008; 226:57-79.
4. Theoharides TC, Makris M, Kalogeromitros D. Allergic inflammation and adipocytokines. Int J Immunopathol Pharmacol 2008: 21:1-4.
5. Huse M, Quann EJ, Davis MM. Shouts, whispers and the kiss of death: directional secretion in T cells. Nat Immunol 2008; 9:1105-1111
6. Galliera E, Locati M, Mantovani A, Corsi MM. Chemokines and bone remodeling. Int J Immunopathol Pharmacol 2008; 21:485-491
7. Di Gioacchino M, Perrone A, Petrarca C, et al. Early cytokine modulation after the rapid induction phase of sublingual immunotherapy with mite monomeric allergoids. Int J Immunopathol Pharmacol 2008; 21:969-976
8. von Vietinghoff S, Ley K. Homeostatic regulation of blood neutrophil counts. J Immunol 2008; 181:5183-5188
9. Becchi C, Pillozzi S, Fabbri LP, et al The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. Int J Immunopathol Pharmacol 2008; 21:697-705.
10. Inoue K, Takano H, Ohnuki M, Yanagisawa R, Sakurai M, Shimada A, Mizushima K, Yoshikawa T. Size effects of nanomaterials on lung inflammation and coagulatory disturbance. Int J Immunopathol Pharmacol 2008; 21:197-206. (Pubitemid 351501016)
11. Fernandez-Cabezudo MJ, Azimullah S, Nurulain SM, Mechkarska M, Lorke DE, Hasan MY, Petroianu GA, Al-Ramadi BK. The organophosphate paraoxon has no demonstrable effect on the murine immune system following subchronic low dose exposure. Int J Immunopathol Pharmacol 2008; 21:891-901.
12. Balboni I, Chan SM, Kattah M, Tenenbaum JD, Butte AJ, Utz PJ. Multiplexed protein array platforms for analysis of autoimmune diseases. Annu Rev Immunol 2006; 24:391-418.
13. Jain S, Yadav H, Sinha PR, Naito Y, Marotta F. Dahl containing probiotic Lactobacillus acidophilus and Lactobacillus casei has a protective effect against Samonella enteritidis infection in mice. Int J Immunopathol Pharmacol 2008; 21:1021-1029
14. Okamoto H, Cujec TP, Yamanaka H, Kamatani N. Molecular aspects of rheumatoid arthritis: role of transcription factors. FEBS J 2008; 275:4463-4470
15. Vivas JR, Regnault B, Michel V, Bussière FI, Avé P, Huerre M, Labigne A, D'Elios MM, Touati E. Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pilori infection. Int J Immunopathol Pharmacol 2008; 21:515-526
16. Minardi D, Lucarini G, Filosa A, Milanese G, Zizzi A, Di Primio R, Montironi R, Muzzonigro G. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up. Int J Immunopathol Pharmacol 2008; 21:447-455 (Pubitemid 351988410)
17. Fieren MW. Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis. Blood Purif 1996; 14:179-187 (Pubitemid 26079586)
18. Sisto M, D'Amore M, Scagliusi P, Mitolo V, Lisi S. Selective TNF-alpha gene silencing attenuates apoptosis in human salivary gland epithelial cells. Int J Immunopathol Pharmacol 2008; 21:1045-1047
19. Tarantino G, Coppola A, Conca P, Cimino E, Di Minno G. Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? Int J Immunopathol Pharmacol 2008; 21:1007-1012
20. Shioya M, Nishida A, Yagi Y, et al. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007;21:480-486 (Pubitemid 47256156)
21. Cordiali-Fei P, Ardigò M, Mastroianni A, Giuliani A, D'Agosto G, Bordignon V, Trento E, Vento A, Berardesca E. Serum cytokines and bioumoral immunological characterization of psoriatic patient sin long term etanercept treatment. Int J Immunopathol Pharmacol 2008; 21:643-649
22. Arend WP, Palmer G, Gabay C. IL-1, IL-18 and IL-33 families of cytokines. Immunol Rev 2008; 223:20-38.
23. Capsoni F, Ongari AM, Frigerio E, Taglioni M, Altomare GF. Effect of efalizumab on neutrophil and monocyte functions in patients with psoriasis. Int J Immunopathol Pharmacol 2008; 21:437-445 (Pubitemid 351988409)
24. Kobayashi H, Lin PC. Molecular characterisation of IL-32 in human endothelial cells. Cytokine 2009; 46:351-358
25. Caorsi C, Cappello P, Ceruti P, Amici A, Marchini C, Novelli F, Forni G, Giovarelli M. CCL 16 enhances the CD8+ and CD4+ cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2. Int J Immunopathol Pharmacol 2008; 21:867-877
26. Vetrano S, Correale C, Borroni EM, Pagano N, Savino B, Locati M, Malesci A, Repici A, Danese S. Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis. Int J Immunopathol Pharmacol 2008; 21:401-407 (Pubitemid 351988404)
27. Brennan F, Beech J. Update on cytokines in rheumatoid arthritis. Curr Opin Rheumatol 2007; 19:296-301.
28. Conti P, Youinou P, Theoharides TC: Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). Autoimmun Rev 2007; 6:131-137 (Pubitemid 46188721)
29. Finocchi A, Palma P, Di Matteo G, Chiriaco M, Lancella L, Simonetti A, Rana I, Livadiotti S, Rossi P. Visceral leishmaniasis revealing chronic granulomatous disease in a child. Int J Immunopathol Pharmacol 2008; 21:739-741
30. Ferdinande L, Demetter P, Perez-Novo C, Waeytens A, Taildeman J, Rottiers I, Rottiers P, De Vos M, Cuvelier CA. Inflamed intestinal mucosa features a specific epithelial expression pattern of indoleamine 2,3-dioxygenase. Int J Immunopathol Pharmacol 2008; 21:289-295 (Pubitemid 351988390)
31. Yasuda A, Takano H, Osakabe N, et al. Cacao liquor proanthocyanidins inhibit lung injury induced by diesel exhaust particles. Int J Immunopathol Pharmacol 2008; 21:279-288 (Pubitemid 351988389)
32. Csernok E, Holle JU, Gross WL. Proteinase 3, protease-activated receptor 2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis. Clin Exp Rheumatol 2008; 26(S):112-117
33. De Vita G, Parti R, Sparacello M, Balistreri CR, Candore G, Caruso C. Impact of different texture of polypropylene mesh in the inflammatory response. Int J Immunopathol Pharmacol 2008; 21:207-214 (Pubitemid 351501017)
34. Marseglia GL, Grignani M, Civallero P, Colombo B, Di Gioacchino M, Marchi A, Perrone A, Ciprandi G. Consequences of long-lasting persistent allergic rhinitis in adolescents. Int J Immunopathol Pharmacol 2008; 21:761-765
35. Chen Q, Carroll HP, Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm 2006; 74:207-228
36. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005; 22:131-142
37. Piancatelli D, Bellotta L, Del Beato T, Duse M, Delia Penna MR. Total IL-12 levels are increased in paediatric atopic dermatitis: correlations with age and disease severity. Int J Immunopathol Pharmacol 2008; 21:359-365 (Pubitemid 351988398)
38. Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH. Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA 2006; 103:3316-3321
39. Inoue K, Takano H, Ohnuki M, et al. Size effects of nanomaterials on lung inflammations and coagulatory disturbance. Int J Immunopathol Pharmacol 2008; 21:197-206. (Pubitemid 351501016)
40. Katsanos GS, Anogianaki A, Castellani JL, et al. Biology of neurotensin: revisited study. Int J Immunopathol Pharmacol 2008; 21:255-259,
41. Raffaelli L, Serini S, Piccioni E, Manicone PF, Berardi D, Perfetti G, Calviello G. N-3 polyunsaturated fatty acid effect in periodontal disease: state of art and possible mechanisms involved. Int J Immunopathol Pharmacol 2008; 21:261-266 (Pubitemid 351988387)
42. Kojima G, Aizawa Y, Yanai Y, Nagaoka K, Takeuchi M, Ohta T, Ikegami H, Ikeda M, Kurimoto M. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J. Immunol 1999; 162:5063-5069 (Pubitemid 29307105)
43. Ghoneum M, Matsuura M, Gollapudi S. Modified arabinoxylan rice brand (MGN3/Biobran) enhances intracellular killing of microbes by human phagocytic cells in vitro. Int J Immunopathol Pharmacol 2008; 21:87-95. (Pubitemid 351501004)
44. Capodicasa E, Cornacchione P, Natalini B, Bartola A, Coaccioli S, Marcon P, Scaringi L. Omeprazole induces apoptosis in normal human polymorphonuclear leucocyctes. Int J Immunopathol Pharmacol 2008; 21:73-85. (Pubitemid 351501003)
45. Sonneck K, Baumgartner C, Rebuzzi L, et al. Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients. Int J Immunopathol Pharmacol 2008; 21:11-21. (Pubitemid 351500997)
46. Papahariadou M, Kalogeromitros D, Athanasiadis GI, et al. Autoimmunity and parasites. Int J Immunopathol Pharmacol 2008; 21:5-9.
47. Selleri S, Palazzo M, Deola S, Wang E, Balsari A, Marincola FM, Rumio C. Induction of proinflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. Int Immunol 2008; 20:961-970
48. Schubert TE, Obermaier F, Ugocsai P, Mannel DN, Echtenacher B, Jofstadter F, Haerle P. Murine models of anaemia of inflammation: extramedullary haemotopoieses represents a species specific difference to human anemia of inflammation that can be eliminated by splenectomy. Int J Immunopathol Pharmacol 2008; 21:577-584
49. Tarhini AA, Kirkwood JM, Gooding WE, Moschos S, Agarwala SS. A phase 2 trial of sequential temozolomide chemotherapy followed by highdose interleukin 2 immunotherapy for metastatic melanoma. Cancer 2008; 113:1632-1640
50. Fulgenzi A, Ticozzi P, Gabel CA, Dell'Antonio G, Quattrini A, Franzone JS, Ferrero ME. Periodate oxidized ATP (oATP) reduces hyperalgesia in mice: involvement of P2X7 receptors and implications for therapy. Int J Immunopathol Pharmacol 2008; 21:61-71. (Pubitemid 351501002)
51. Marcucci F, Incorvaia C, Sensi L, et al. Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy. Int J Immunopathol Pharmacol 2008; 21:609-613
52. Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, Dinarello CA. Endogenous IL-32 controls cytokine and HIV.1 production. J Immunol 2008; 181:557-565
53. Tarantino G, Gagliardi G, Conca P. Do thyroid abnormalities detected in patients treated for HCV-related chronic hepatitis persist? Int J Immunopathol Pharmacol 2008; 21:467-469
54. Mariotti M, Bolognese F, Ferrè S, Leidi M, Maier JA. Impact of extracellular HIV-TAT on the regulation of EDF-1 levels in human endothelial cells. Int J Immunopathol Pharmacol 2008; 21:409-414 (Pubitemid 351988405)
55. Lalle E, Sacchi A, Abbate I, et al. Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Int J Immunopathol Pharmacol 2008; 21:161-171 (Pubitemid 351501012)
56. Putignani L, Antonucci G, Paglia MG, Vincenzi L, Festa A, De Mori P, Loiacono L, Visca P. Cryptococcal lymphadenitis as a manifestation of immune reconstitution inflammatory syndrome in an HIV-positive patient: a case report and review of the literature. Int J Immunopathol Pharmacol 2008; 21:751-756
57. Cardelli P, Ferraironi M, Amodeo R, et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 2008; 21:43-49 (Pubitemid 351501000)
58. Gratziou C, Rovina N, Makris M, Simoes DC, Papapetropoulos A, Roussos C. Breath markers of oxidative stress and airway inflammation in season allergic rhinitis. Int J Immunopathol Pharmacol 2008; 21:949-957
59. Martelius T, Salmi M, Krogerus L, et al. Inhibition of semicarbazide-sensitive amine oxidases decreases lymphocyte infiltration in the early phases of rat liver allograft rejection. Int J Immunopathol Pharmacol 2008; 21:911-920
60. Chang CP, Lei HY. Autophagy induction in T cell-independent acute hepatitis induced by concanavalin A in SCID/NOD mice. Int J Immunopathol Pharmacol 2008; 21:817-826
61. Li W, Yang F, Liu Y, et al. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol 2009; 39:1019-1024
62. Inoue K, Takano H, Yanagisawa R, Sakurai M, Shimada A, Satoh M, Yoshino S, Yamaki K, Yoshikawa T. Antioxidative role of interleukin-6 in septic lung injury in mice. Int J Immunopathol Pharmacol 2008; 21:501-507
63. Dinarello CA, Kim SH. IL-32, a novel cytokine with a possibile role in disease. Ann Rheum Dis 2006; 65(S):61-64
64. Kim KH, Shim JH, Seo EH, et al. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA. J Immunol Methods 2008; 333:38-50.
65. Lehnerdt GF, Bankfalvi A, Grehl S, Adamzik M, Lang S, Schmid KW, Siffert W, Riemann K. No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region. In J Immunopathol Pharmacol 2008; 21:827-832
66. Nishida A, Andoh A, Shioya M, KimòMitsuyama S, Takayanagi A, Fujiyama Y. Phosphatidylinositol 3-kinase/Akt signalling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2008; 204:831-838 (Pubitemid 351468765)
67. Mitola S, Sorbello V, Ponte E, et al. Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease. Int J Immunopathol Pharmacol 2008; 21:951-965